Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Receivables - Other: 2013-2017

  • Ocular Therapeutix's Receivables - Other was N/A to $688,000 in Q1 2017 from the same period last year, while for Mar 2017 it was $688,000, marking a year-over-year change of. This contributed to the annual value of $19,000 for FY2013, which is N/A change from last year.
  • As of Q1 2017, Ocular Therapeutix's Receivables - Other stood at $688,000, which was up 68,700.00% from $1,000 recorded in Q3 2014.
  • Over the past 5 years, Ocular Therapeutix's Receivables - Other peaked at $688,000 during Q1 2017, and registered a low of $1,000 during Q2 2014.
  • In the last 1 years, Ocular Therapeutix's Receivables - Other had a median value of $688,000 in 2017 and averaged $688,000.